Brief: Rani Therapeutics Q4 Operating Expenses USD 15.986 Million
31/03/2025 23:43
March 31 (Reuters) - Rani Therapeutics Holdings Inc RANI.O: RANI THERAPEUTICS Q4 OPERATING EXPENSES USD 15.986 MILLION RANI THERAPEUTICS Q4 OPERATING INCOME USD -14.958 MILLION RANI THERAPEUTICS Q4 NET INCOME USD -15.721 MILLION RANI THERAPEUTICS HOLDINGS: CASH, CASH EQUIVALENTS & MARKETABLE SECURITIES SUFFICIENT TO FUND OPERATIONS INTO Q3 Q4 LOSS PER SHARE $0.27 Q4 EARNINGS PER SHARE VIEW $-0.25 -- LSEG IBES DATA Source text: ID:nGNX5FWCml Further company coverage: RANI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rani Therapeutics Holdings
See all newsRani Therapeutics Q2 net loss narrows as revenue rises helped by Chugai agreement
Brief: Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Pegbio Co Enters MoU With Rani Therapeutics
Brief: Rani Therapeutics Announces R&D Collaboration With PegBio
Rani Therapeutics Q1 contract revenue rises on Chugai collaboration; announces CFO transition